1. Splenic and PB immune recovery in neoadjuvant treated gastrointestinal cancer patients
   Kathryn E. Cole et al, 2022, International Immunopharmacology CrossRef
2. Arginase Inhibitors: A Rational Approach Over One Century
   Marc Pudlo et al, 2017, Medicinal Research Reviews CrossRef
3. Arginase as a Potential Biomarker of Disease Progression: A Molecular Imaging Perspective
   Gonçalo S. Clemente et al, 2020, International Journal of Molecular Sciences CrossRef
4. Human splenic myeloid derived suppressor cells: Phenotypic and clustering analysis
   Kathryn E. Cole et al, 2021, Cellular Immunology CrossRef
5. Development of a new nano arginase HPLC capillary column for the fast screening of arginase inhibitors and evaluation of their binding affinity
   Claire André et al, 2021, Journal of Chromatography B CrossRef
6. Sepsis-Induced Inhibition of Contractile Function of Lymphatic Nodes
   M. E. Kosareva et al, 2024, Bulletin of Experimental Biology and Medicine CrossRef
7. Galectin-1 Reduces Neuroinflammation via Modulation of Nitric Oxide-Arginase Signaling in HIV-1 Transfected Microglia: a Gold Nanoparticle-Galectin-1 “Nanoplex” a Possible Neurotherapeutic?
   Ravikumar Aalinkeel et al, 2017, Journal of Neuroimmune Pharmacology CrossRef
8. Regulation of T Cells in Cancer by Nitric Oxide
   Inesa Navasardyan et al, 2021, Cells CrossRef
9. Arginase is upregulated in healthy women infected by oncogenic HPV types
   Moufida Souid et al, 2023, Biomarkers CrossRef